![Alzheimer's Speaks artwork](https://is3-ssl.mzstatic.com/image/thumb/Podcasts123/v4/5c/b6/df/5cb6dfde-0ffd-038c-fdd6-3d411ef886f9/mza_5594310225118758882.jpg/100x100bb.jpg)
Looking Into The Future of Dementia - Causes and Treatments
Alzheimer's Speaks
English - October 18, 2023 21:00 - 47 minutes - 21.9 MB - ★★★★ - 6 ratingsHealth & Fitness dementia alzheimers mci lewy body ftd vascular memory care caregiving dementia friendly alzheimer's speaks Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Lori La Bey welcomes back Sharon L. Rogers, the CEO of AmyriAD Therapeutics. Sharon was previously chief of research at Eisai, where she played a leading role in developing Aricept, the top-selling Alzheimer's medication on the market.
Learn:
Who is really funding early-stage trials? What is the difference between Pharma and Social Therapies? Do we know how many forms of dementia there are? What does having a complex dementia mean? Does a change in diagnosis affect a clinical trial? About the Domino’s Study. Will there be a silver bullet medication for dementia in the near future?
Listen and Subscribe to Alzheimer’s Speaks on Apple Podcast
https://podcasts.apple.com/us/podcast/alzheimers-speaks/id986940432
Listen and Subscribe to Alzheimer’s Speaks on Spotify
https://open.spotify.com/show/255okRnEgfCUqXq1NWcrT3
Contact AmyriAD Therapeutics
Website https://amyriadtherapeutics.com/
LinkedIn https://www.linkedin.com/company/amyriad-therapeutics/
Twitter https://twitter.com/AmyriAD_Tx
Contact Lori La Bey with questions or branding needs at https://www.alzheimersspeaks.com/
Alzheimer's Speaks Radio - Shifting dementia care from crisis to comfort around the world one episode at a time by raising all voices and delivering sound news, not just sound bites since 2011.
Alzheimer's Speaks is part of the Senior Resource Podcast Network
Support this Show: https://alzheimersspeaks.com/donate-now/
See omnystudio.com/listener for privacy information.